Back to search

Article

Distinguishing Pseudotransduction and True Transduction Enables Characterization and Bioengineering of Extracellular Vesicle-Adeno-Associated Virus Vectors

2025-07-04

Abstract excerpt

<h4>ABSTRACT</h4> Adeno-associated virus (AAV) gene therapies have achieved some clinical success, with multiple products reaching regulatory approval. Encapsulation of AAV vectors within engineered extracellular vesicles (EVs) is an emerging strategy which could help overcome challenges including pre-existing anti-capsid immunity and the need for controlling targeting and tropism. To guide the development of EV-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
25e2e398-88ce-53d5-97a4-c0af547d54b9
DOI
10.1101/2025.07.02.662894
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Distinguishing Pseudotransduction and True Transduction Enables Characterization and Bioengineering of Extracellular Vesicle-Adeno-Associated Virus VectorsDOI 10.1101/2025.07.02.662894
Select a neighboring publication to make it the new centre.